Improved pH measurements with a single PARACEST MRI contrast agent

Contrast Media and Molecular Imaging

Volumn 7, Issue 1, 2012, Pages 26-34

  Sheth, Vipul R ^a   Liu, Guanshu ^b,c   Li, Yuguo ^d   Pagel, Mark D ^e,f,g  

^a Case Western Reserve University   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e University of Arizona   (United States)

^f University of Arizona   (United States)

^g UNIVERSITY OF ARIZONA   (United States)

Author keywords

Contrast agent; MRI; PARACEST; PH

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7 TRIACETIC ACID ORTHOAMINOANILIDE; AMIDE; AMINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG; YTTERBIUM;

ACCURACY; ARTICLE; CALIBRATION; HUMAN; MAGNETIC FIELD; PH; PH MEASUREMENT; PRIORITY JOURNAL; RELAXATION TIME; TEMPERATURE; THERAPY EFFECT;

CALIBRATION; CONTRAST MEDIA; COORDINATION COMPLEXES; EXTRACELLULAR FLUID; HYDROGEN-ION CONCENTRATION; LEAST-SQUARES ANALYSIS; MAGNETIC RESONANCE IMAGING; MODELS, CHEMICAL; MOLECULAR STRUCTURE; OSMOLAR CONCENTRATION; PROTONS; TEMPERATURE; TUMOR MICROENVIRONMENT; WATER;

EID: 84863177886     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.460     Document Type: Article

References (47)

1. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
2. Gillies RJ, Gatenby RA. Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Met Rev 2007; 26: 311-317.
3. Raghunand N, He X, van Sluis R, Mahoney B, Baggett B, Taylor CW, Paine-Murrieta G, Roe D, Bhujwalla ZM, Gillies RJ. Enhancement of chemotherapy by manipulation of tumor pH. Br J Cancer 1999; 80(7): 1005-1011.
4. Mahoney BP, Raghunand N, Baggett B, Gillies RJ. Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochem Pharmacol 2003; 66(7): 1207-1218.
5. Raghunand N, Mahoney BP, Gillies RJ. Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem Pharmacol 2003; 66(7): 1219-1229.
6. Thistlethwaite AJ, Leeper DB, Moylan DJ, Nerlinger RE. pH distribution in human tumors. Int J Radiation Oncol Biol Phys 1985; 11(9): 1647-1652.
7. Mordon S, Devoisselle JM, Maunoury V. In vivo pH measurement and imaging of tumor tissue using a pH-sensitive fluorescent probe (5, 6-carboxyfluorescein): instrumental and experimental studies. Photochem Photobiol 1994; 60(3): 274-279.
8. Hassan M, Riley J, Chernomordik V, Smith P, Pursley R, Lee SB, Capala J, Gandjbakhche AH. Fluorescence lifetime imaging system for in vivo studies. Mol Imag 2007; 6: 229-236.
9. Khramtsov VV, Grigor'ev IA, Foster MA, Lurie DJ Nicholson I. Biological applications of spin pH probes. Cell Mol Biol 2000; 46: 1361.
10. Vavere AL, Biddlecombe GB, Spees WM, Garbow JR, Wijesinghe D, Andreev OA, Engelman DM, Reshetnyak YK, Lewis JS. A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Res 2009; 69: 4510-4516.
11. Gillies RJ, Raghunand N, Garcia-Martin ML, Gatenby RA. pH imaging. A review of pH measurement methods and applications in cancers. IEEE Eng Med Biol Magn 2004; 23(5): 57-64.
12. 13C-labelled bicarbonate. Nature 2008; 453: 940-943.
13. Yoo B, Pagel MD. An overview of responsive MRI contrast agents for molecular imaging. Front Biosci 2008; 13: 1733-1752.
14. Raghunand N, Zhang S, Sherry AD, Gillies RJ. In vivo magnetic resonance imaging of tissue pH using a novel pH-sensitive contrast agent, GdDOTP-4Amp. Acad Radiol 2002; 9(2): S481-S483.
15. Raghunand N, Howison C, Sherry AD, Zhang S, Gillies RJ. Renal and systemic pH imaging by contrast-enhanced MRI. Magn Reson Med 2003; 49: 249-257.
16. Garcia-Martin ML, Martinez GV, Raghunand N, Sherry AD, Zhang S, Gillies RJ. High resolution pHe imaging of rat glioma using pH-dependent relaxivity. Magn Reson Med 2006; 55(2): 309-315.
17. Aime S, Fedeli F, Sanino A, Terreno EA. R-2/R-1 ratiometric procedure for a concentration-independent, pH-responsive, Gd(III)-based MRI agent. J Am Chem Soc 2006; 128: 11326-11327.
18. 2 contrast agents. NMR Biomed 2011; doi: 10.1002/nbm.1701
19. Frullano L, Catana C, Benner T, Sherry AD, Caravan P. Bimodal MR-PET agent for quantitative pH imaging. Angew Chem Int Ed 2010; 49: 2382-2384.
20. Ward KM, Balaban RS. Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn Reson Med 2000; 44(5): 799-802.
21. Longo DL, Colombo W, Dastrù W, Pogi L, Tedoldi F, Terreno E, Uggeri F, Aime S. Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys: in vivo studies in mice at 7 T. Magn Reson Med 2011; 65(1): 202-211.
22. Zhang S, Merritt M, Woessner DE, Lenkinski RE, Sherry AD. PARACEST agents: moculating MRI contrast via water proton exchange. Acc Chem Res 2003; 36: 783-790.
23. Terreno E, Delli Castelli D, Cravotto G, Milone L, Aime S. Ln(III)-DOTAMGly complexes: a versatile series to assess the determinants of the efficacy of paramagnetic chemical exchange saturation transfer agents for magnetic resonance imaging applications. Invest Radiol 2004; 39: 235-243.
24. Aime S, Delli Castelli D Terreno E. Novel pH-reporter MRI contrast agents. Angew Chem Int Ed 2002; 41(2): 4334-4336.
25. Delli Castelli D, Terreno E, Aime S. YbIII-HPDO3A: a dual pH- and temperature-responsive CEST agent. Angew Chemie Int Ed 2011; 50(8): 1798-1800.
26. Wu Y, Soesbe TC, Kiefer GE, Zhao P, Sherry AD. A responsive europium(III) chelate that provides a direct readout of pH by MRI. J Am Chem Soc 2010; 132(40): 14002-14003.
27. Liu G, Lu Y, Pagel MD. Design and characterization of new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide. Magn Reson Med 2007; 58: 1249-1256.
28. Li Y, Sheth VR, Liu G, Pagel MD. A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity. Contrast Media Mol Imag 2010; doi: 10.1002/cmmi.421
29. Woessner DE, Zhang S, Merritt ME, Sherry AD. Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI. Magn Reson Med 2005; 53(4): 790-799.
30. Englander SW, Downer NW, Teitelbaum H. Hydrogen exchange. Annu Rev Biochem 1972; 41: 903-924.
31. Barksdale AD, Rosenberg A. Acquisition and interpretation of hydrogen exchange data from peptides, polymers, and proteins. Meth Biochem Anal 1982; 28: 1-113.
32. Covington AK, Robinson RA, Bates RG. Ionization constant of deuterium oxide from 5 to 50 degrees. J Phys Chem 1966; 70(12): 3820-3824.
33. Henkelman M, Huang X, Xiang QS, Stanisz GJ, Swanson SD, Bronskill MJ. Quantitative interpretation of magnetization transfer. Magn Reson Med 1993; 29(6): 759-766.
34. Aime S, Barge A, Delli Castelli D, Fedeli F, Mortillaro A, Nielsen FU, Terreno E. Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn Reson Med 2002; 47: 639-648.
35. McMahon MT, Gilad AA, Zhou J, Sun PZ, Bulte JWM, van Zijl PCM. Quantifying exchange rates in chemical exchange saturation transfer agents using the saturation time and saturation power dependencies of the magnetization transfer effects on the magnetic resonance imaging signal (QUEST and QUESP): pH calibration for poly-l-lysine and a starburst dendrimer. Magn Reson Med 2006; 55: 836-847.
36. Woods M, Woessner DE, Sherry AD. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. Chem Soc Rev 2006; 35: 500-511.
37. Gil S, Zaderenzo P, Cruz F, Cerdán S, Ballesteros P. Imidazol-1-ylalkanoic acids as extrinsic 1H NMR probes for the determination of intracellular pH, extracellular pH and cell volume. Bioorg Med Chem 1994; 2: 305-314.
38. Welch BL The generalization of 'Student's' problem when several different population variances are involved. Biometrika 1947; 34(1-2): 28-35.
39. Ali MM, Liu G, Shah T, Flask C, Pagel MD. Using two chemical exchange saturation trasnfer magnetic resonance imaging contrast agents for molecular imaging studies. Acc Chem Res 2009; 42(7): 915-924.
40. Gutowsky H, Cheng H. Determination of kinetic parameters by the frequency dependence of the NMR coalescence temperature. J Chem Phys 1973; 63: 2439-2441.
41. Liu G, Li Y, Sheth VR, Pagel MD. Imaging in vivo extracellular pH with a single PARACEST MRI contrast agent. Mol Imag 2011 (in press).
42. Bates RG. Electrometric pH Determinations: Theory and Practice. Wiley: New York, 1954.
43. Van Geet AL. Calibration of the methanol and glycol nuclear magnetic resonance thermometers with a static thermistor probe. Anal Chem 1968; 40(14): 2227-2229.
44. Henoumont C, Laurent S, Vander Elst L How to perform accurate and reliable measurements of longitudinal and transverse relaxation times of MRI contrast media in aqueous solutions Contrast Media Mol Imag 2009; 4(6): 312-321.
45. van Sluis R, Bhujwalla ZM, Raghunand N, Ballesteros P, Alvarez J, Cerdan S, Galons JP, Gillies RJ. In vivo imaging of extracellular pH using 1H MRSI. Magn Reson Med 1999; 41(4): 743-750.
46. Grad J, Bryant RG. Nuclear magnetic cross-relaxation spectroscopy. J Magn Reson 1999; 90(1): 1-8.
47. Terreno E, Stancanello J, Longo D, Delli Castelli D, Milone L, Sanders HMHF, Kok MB, Uggeri F Aime S. Methods for an improved detection of the MRI-CEST effect, Contrast Media Mol Imag 2009; 4(5): 237-247.